Fundraising Fox

Polaris Partners2026 Investments

5 investments dated 2026 · listed companies and verified rows first · show all

ByHeartbyheart.comMay 2026SEC filingmedium confidence

ByHeart is an infant formula company navigating an FDA return-to-market process following a product outbreak investigation.

ConsumerDirect to ConsumerFoodTechHealthtechNew York, US

Mia B. Funt(Executive Officer, Director)Ron Belldegrun(Executive Officer, Director, Promoter)Mia Funt(Founder)inGeorg Krause-Vilmar(Executive Officer)Niall Mullane(Executive Officer)

Board seatAmy Schulman· per SEC Form D · $95.5M raise · filed May 2026

Co-investorsEvolution VC PartnersOCV PartnersRed Sea VenturesVida Ventures

Loblob.comin𝕏Jan 2026

Lob provides software and hardware infrastructure for automating, personalizing, and tracking direct mail campaigns at scale.

Enterprise SoftwareLogistics & Supply ChainMarketing TechSaaSNew York City, US

Eduardo Browne(Executive Officer)Donnell Vanker(Executive Officer)Harry Zhang(Founder)Leore Avidar(Founder)

Co-investorsFloodgateFrontline VenturesStructural CapitalTodd and Rahul’s Angel FundY CombinatorFirst Round Capital+3 more

Sea PharmaceuticalsMay 2026 · $70K
Tavo BiotherapeuticsSeries A · Jun 2026 · $17M
TropicSeries C · Mar 2026 · $105M

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.